These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7050637)

  • 1. Pigments and antibiogram of transconjugants from nonpigmented mutants of Serratia marcescens.
    Qian HL; Feng JS; Tsang JC
    Microbios; 1982; 33(132):101-10. PubMed ID: 7050637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type beta-lactamases encoded on a single plasmid.
    Zhao WH; Hu ZQ; Chen G; Matsushita K; Fukuchi K; Shimamura T
    Microbiol Res; 2007; 162(1):46-52. PubMed ID: 16875810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a red-pigmented bacterium producing a potent anti-tumor N-alkylated prodigiosin as Serratia marcescens.
    Deorukhkar AA; Chander R; Ghosh SB; Sainis KB
    Res Microbiol; 2007 Jun; 158(5):399-404. PubMed ID: 17467243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth depression of Serratia marcescens by plasmids that belong to incompatibility group P.
    Platt DJ; Chesham JS
    Microbios; 1990; 63(256-257):151-7. PubMed ID: 2172750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of prodigiosin by white strains of Serratia marcescens isolated from patients.
    Ding MJ; Williams RP
    J Clin Microbiol; 1983 Mar; 17(3):476-80. PubMed ID: 6341402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigmentation and acriflavine resistance in Serratia marcescens.
    Woods DR; Mosmann TR; Hanson S; Hendry DA
    J Bacteriol; 1971 Nov; 108(2):765-9. PubMed ID: 4942763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SELECTIVE INHIBITION OF PROLINE-INDUCED PIGMENTATION IN WASHED CELLS OF SERRATIA MARCESCENS.
    BLIZZARD JL; PETERSON GE
    J Bacteriol; 1963 May; 85(5):1136-40. PubMed ID: 14044006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and co-cultivation of two mutant strains harboring key precursor genes to produce prodigiosin.
    Chen WC; Tsai MJ; Soo PC; Wang LF; Tsai SL; Chang YK; Wei YH
    J Biosci Bioeng; 2018 Dec; 126(6):783-789. PubMed ID: 30401454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid profiles in pigmented and non-pigmented strains of S. marcescens.
    Pizzimenti FC; Nostro A; Marino A; Villari A; Verzera A; Trozzi A; Alonzo V
    New Microbiol; 1999 Apr; 22(2):91-8. PubMed ID: 10322607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A relationship between R plasmids and increased incidence of nonpigmenting drug-resistant Serratia marcescens from clinical sources].
    Muto Y; Tsuji A; Kaneko Y; Goto S
    Nihon Saikingaku Zasshi; 1982 Nov; 37(6):931-7. PubMed ID: 6763638
    [No Abstract]   [Full Text] [Related]  

  • 12. Thiamine-induced formation of the monopyrrole moiety of prodigiosin.
    Goldschmidt MC; Williams RP
    J Bacteriol; 1968 Sep; 96(3):609-16. PubMed ID: 4895047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and expression in Escherichia coli of Serratia marcescens genes encoding prodigiosin biosynthesis.
    Dauenhauer SA; Hull RA; Williams RP
    J Bacteriol; 1984 Jun; 158(3):1128-32. PubMed ID: 6233267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of pigmented and nonpigmented mutants of Serratia marcescens with reduced cell surface hydrophobicity.
    Rosenberg M
    J Bacteriol; 1984 Oct; 160(1):480-2. PubMed ID: 6384200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The red pigment prodigiosin is not an essential virulence factor in entomopathogenic Serratia marcescens.
    Zhou W; Li J; Chen J; Liu X; Xiang T; Zhang L; Wan Y
    J Invertebr Pathol; 2016 May; 136():92-4. PubMed ID: 27000435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intergeneric bacterial conjugation in crosses of Vibrio cholerae biotype proteus X Serratia marcescens].
    Sokurova EN; Polushkina EF; Golovina VS
    Genetika; 1982 Oct; 18(10):1603-12. PubMed ID: 6757054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of drug-resistance plasmids by conjugation from nosocomial strains of Serratia marcescens to Escherichia coli in biological fluids of human origin.
    Mendez FJ; Mendoza MC; Llaneza JJ; Hardisson C
    J Hosp Infect; 1982 Sep; 3(3):285-92. PubMed ID: 6183321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmid-determined resistance to fosfomycin in Serratia marcescens.
    Mendoza C; Garcia JM; Llaneza J; Mendez FJ; Hardisson C; Ortiz JM
    Antimicrob Agents Chemother; 1980 Aug; 18(2):215-9. PubMed ID: 7004337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defects in prodigiosin formation by L-forms of Serratia marcescens.
    Potter CS; Hubert EG; Montgomerie JZ; Kalmanson GM; Guze LB
    J Bacteriol; 1973 Dec; 116(3):1343-5. PubMed ID: 4584812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of class 1 integrons and antimicrobial resistance in CTX-M-3-producing Serratia marcescens isolates from southern Taiwan.
    Peng CF; Lee MF; Fu HT; Chen YJ; Hsu HJ
    Jpn J Infect Dis; 2007 Sep; 60(5):250-6. PubMed ID: 17881862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.